FIU20060390U0 - Harvinaisten maametalliyhdisteiden käyttö munuaiskivisairauden ehkäisemiseksi - Google Patents

Harvinaisten maametalliyhdisteiden käyttö munuaiskivisairauden ehkäisemiseksi

Info

Publication number
FIU20060390U0
FIU20060390U0 FI20060390U FIU20060390U FIU20060390U0 FI U20060390 U0 FIU20060390 U0 FI U20060390U0 FI 20060390 U FI20060390 U FI 20060390U FI U20060390 U FIU20060390 U FI U20060390U FI U20060390 U0 FIU20060390 U0 FI U20060390U0
Authority
FI
Finland
Prior art keywords
oxalate
rare earth
lanthanum carbonate
prevention
metal compounds
Prior art date
Application number
FI20060390U
Other languages
English (en)
Swedish (sv)
Inventor
Simon Bates
Donald Hallenbeck
Original Assignee
Shire Int Licensing Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Int Licensing Bv filed Critical Shire Int Licensing Bv
Publication of FIU20060390U0 publication Critical patent/FIU20060390U0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • External Artificial Organs (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI20060390U 2001-04-23 2006-09-22 Harvinaisten maametalliyhdisteiden käyttö munuaiskivisairauden ehkäisemiseksi FIU20060390U0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28590101P 2001-04-23 2001-04-23
PCT/US2002/013000 WO2002085348A1 (en) 2001-04-23 2002-04-22 Use of rare earth compounds for the prevention of kidney stone disease

Publications (1)

Publication Number Publication Date
FIU20060390U0 true FIU20060390U0 (fi) 2006-09-22

Family

ID=23096166

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20060390U FIU20060390U0 (fi) 2001-04-23 2006-09-22 Harvinaisten maametalliyhdisteiden käyttö munuaiskivisairauden ehkäisemiseksi

Country Status (26)

Country Link
US (2) US7192609B2 (fi)
EP (1) EP1389102B1 (fi)
JP (2) JP4515030B2 (fi)
KR (1) KR100956013B1 (fi)
CN (1) CN100438866C (fi)
AT (1) ATE499943T1 (fi)
AU (2) AU2002307543B2 (fi)
BR (1) BR0209072A (fi)
CA (1) CA2442414C (fi)
CY (1) CY1112049T1 (fi)
CZ (2) CZ298280B6 (fi)
DE (2) DE60239329D1 (fi)
DK (2) DK1389102T3 (fi)
ES (1) ES2362271T3 (fi)
FI (1) FIU20060390U0 (fi)
HK (1) HK1064030A1 (fi)
HU (1) HUP0303938A3 (fi)
MX (1) MXPA03009668A (fi)
NO (1) NO20034704L (fi)
NZ (1) NZ528818A (fi)
PL (1) PL370642A1 (fi)
PT (1) PT1389102E (fi)
RU (1) RU2296584C2 (fi)
SI (1) SI1389102T1 (fi)
WO (1) WO2002085348A1 (fi)
ZA (1) ZA200308112B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
EA012798B1 (ru) * 2003-08-26 2009-12-30 Шир Холдингз Аг Фармацевтический состав, содержащий карбонат лантана (варианты)
BRPI0513603A (pt) * 2004-07-27 2008-05-13 Shire Pharmaceuticals Inc uso de hidroxicarbonato de lantánio e composição farmacêutica
US20070104799A1 (en) * 2005-11-09 2007-05-10 Shire International Licensing B.V. Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds
US8974824B2 (en) * 2008-03-26 2015-03-10 Mylan Laboratories Ltd. Lanthanum composition
EP3848040A1 (en) 2010-05-12 2021-07-14 Spectrum Pharmaceuticals, Inc. Lanthanum dioxycarbonate and use
RU2657755C1 (ru) * 2017-07-10 2018-06-15 Александр Александрович Кролевец Способ получения нанокапсул солей лантаноидов в каррагинане
AU2021218729A1 (en) * 2020-02-13 2022-09-08 Lawrence Livermore National Security, Llc Methods of sequestering target elements
WO2024003337A1 (en) * 2022-07-01 2024-01-04 Amgmt Orally administrable pharmaceutical dosage form comprising lanthanum and its use in a method of treatment of hyperoxaluria

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1668562C3 (de) * 1967-12-08 1975-01-30 Pharmazeutische Fabrik Evers & Co, 2080 Pinneberg Cergluconat, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Präparate
DE3046580A1 (de) * 1980-12-11 1982-07-01 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
DE3213139A1 (de) * 1980-12-11 1983-10-20 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
JPS614529A (ja) * 1984-06-15 1986-01-10 Asahi Chem Ind Co Ltd リン酸イオンの吸着剤
JPS614528A (ja) 1984-06-15 1986-01-10 Arubatsuku Service Kk 水溶性ガスの高純度溶液の製造装置
JPH06705B2 (ja) * 1985-12-19 1994-01-05 旭化成工業株式会社 リン酸イオンの固定化剤
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate
US5342604A (en) * 1988-10-31 1994-08-30 The Dow Chemical Company Complexes possessing ortho ligating functionality
US5696239A (en) * 1988-10-31 1997-12-09 The Dow Chemical Company Conjugates possessing ortho ligating functionality and complexes thereof
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
RU2061040C1 (ru) 1994-05-23 1996-05-27 Акционерное общество "Русский йогурт" Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для получения препаратов и продуктов питания для профилактики и лечения гипероксалурии
CA2128199C (en) * 1994-07-15 1997-02-04 Bernard Charles Sherman Stable solid pharmaceutical compositions containing enalapril maleate
GB9506126D0 (en) 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
US5951958A (en) * 1996-07-10 1999-09-14 Shin-Etsu Chemical Co., Ltd. Method for the preparation of rare earth phosphate of low overstoichiometric phosphorous content
US5902825A (en) * 1997-01-07 1999-05-11 Mitreoak, Ltd. Composition and method for the palliation of pain associated with diseases of the bone and bone joints
EP2033651A1 (en) 1997-05-23 2009-03-11 OxThera, Inc., Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US20010014352A1 (en) * 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
US6160016A (en) * 1999-12-22 2000-12-12 Wisconsin Alumni Research Foundation Phosphorus binder
TW200412956A (en) * 2002-09-30 2004-08-01 Schering Corp Methods for treating disorders of calcium homeostasis
EA012798B1 (ru) * 2003-08-26 2009-12-30 Шир Холдингз Аг Фармацевтический состав, содержащий карбонат лантана (варианты)

Also Published As

Publication number Publication date
CA2442414C (en) 2011-02-01
JP2005507369A (ja) 2005-03-17
DK1389102T3 (da) 2011-06-06
EP1389102A4 (en) 2004-07-14
JP4515030B2 (ja) 2010-07-28
CA2442414A1 (en) 2002-10-31
RU2296584C2 (ru) 2007-04-10
DE60239329D1 (de) 2011-04-14
DE20221760U1 (de) 2007-08-16
SI1389102T1 (sl) 2011-07-29
AU2002307543B2 (en) 2006-04-27
AU2006203055B2 (en) 2008-12-18
PL370642A1 (en) 2005-05-30
ZA200308112B (en) 2005-01-17
NO20034704D0 (no) 2003-10-21
NZ528818A (en) 2008-09-26
AU2006203055A1 (en) 2006-08-10
US20020155168A1 (en) 2002-10-24
KR20040018362A (ko) 2004-03-03
EP1389102B1 (en) 2011-03-02
CY1112049T1 (el) 2015-11-04
PT1389102E (pt) 2011-06-07
DK200600251U4 (da) 2007-12-28
CZ20032880A3 (cs) 2004-01-14
CN1503668A (zh) 2004-06-09
NO20034704L (no) 2003-11-25
RU2003133991A (ru) 2005-04-20
BR0209072A (pt) 2006-02-07
CZ298280B6 (cs) 2007-08-15
US7192609B2 (en) 2007-03-20
HUP0303938A3 (en) 2012-09-28
JP2009173684A (ja) 2009-08-06
EP1389102A1 (en) 2004-02-18
WO2002085348A1 (en) 2002-10-31
CN100438866C (zh) 2008-12-03
HUP0303938A2 (hu) 2004-04-28
HK1064030A1 (en) 2005-01-21
DK200600251U1 (da) 2007-01-12
ES2362271T3 (es) 2011-06-30
US20070116782A1 (en) 2007-05-24
MXPA03009668A (es) 2004-02-12
KR100956013B1 (ko) 2010-05-06
CZ17802U1 (cs) 2007-09-03
ATE499943T1 (de) 2011-03-15

Similar Documents

Publication Publication Date Title
FIU20060390U0 (fi) Harvinaisten maametalliyhdisteiden käyttö munuaiskivisairauden ehkäisemiseksi
ATE428439T1 (de) Flüssige zusammensetzung aus faktor vii polypeptiden
DE60104978D1 (de) Selektive kristallisierung von 3-pyridyl-1-hydroxyethyliden-1,1-bisphosphonsäure natrium als hemipentahydrat oder monohydrat
NO20025819D0 (no) Natriumsalt og kontrastmiddel inneholdende dette
ATE367429T1 (de) Stabilisierte saure chlorbleichmittelzusammensetzung und verfahren zur anwendung
RU94017851A (ru) Ингибиторы протеолитических ферментов на основе производных сахарина, фармацевтическая композиция для лечения дегеративных заболеваний
RU2004102395A (ru) Жидкая композиция, включающая сложный эфир полиоксиэтиленсорбита и жирной кислоты
ATE218802T1 (de) Spüllösung für organe und gewebe
ATE470147T1 (de) Verfahren und mittel zur bestimmung von gesamthärte
BR0014389A (pt) Compostos de ligação metálica e seus usos
ATE242175T1 (de) Verfahren zur reinigung eines sauren gases
ATE254950T1 (de) Verfahren zur reinigung wässriger pufferlösungen
Rodionova et al. Ca2+-activator of the luminescence system of the earthworms Henlea sp.,(Annelida: Clitellata: Oligochaeta: Enchytraeidae)
RU95117286A (ru) Ирригационный раствор для офтальмологических операций
EA199900710A1 (ru) Кристаллическая гидратированная натриевая соль (е)-4,6-дихлор-3-(2-оксо-1-фенилпирролидин-3-илиденметил)-1н-индол-2-карбоновой кислоты
DE60233353D1 (de) Verfahren zur behandlung von halitose
DE60224839D1 (de) Verfahren zur lagerung von tetrazoliumverbindungen, dafür bestimmter stabilisator und nach dem verfahren aufbewahrte tetrazoliumverbindungsreagenz lösung
RU2003117105A (ru) Состав для обработки материалов
RU99104271A (ru) Состав для химического расширения каналов
RU2003120703A (ru) Способ регенерации костной ткани в эксперименте
ATE275952T1 (de) Verfahren zur auffindung von nukleotidsyntheseinhibitoren mit weniger nebenwirkungen
RU96114220A (ru) Твердый состав для обеззараживания и очистки воды
CO4770984A1 (es) Compuesto de ciclohexapeptidil bis-amina, composiciones que lo contienen y metodos de uso
RU2000118306A (ru) Способ укоренения черенков роз
TH57075B (th) สารผสม

Legal Events

Date Code Title Description
FDU Application lapsed